Literature DB >> 10815771

3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands.

J J Lozano1, M Pastor, G Cruciani, K Gaedt, N B Centeno, F Gago, F Sanz.   

Abstract

Many heterocyclic amines (HCA) present in cooked food exert a genotoxic activity when they are metabolised (N-oxidated) by the human cytochrome P450 1A2 (CYP1A2h). In order to rationalize the observed differences in activity of this enzyme on a series of 12 HCA, 3D-QSAR methods were applied on the basis of models of HCA-CYP1A2h complexes. The CYP1A2h enzyme model has been previously reported and was built by homology modeling based on cytochrome P450 BM3. The complexes were automatically generated applying the AUTODOCK software and refined using AMBER. A COMBINE analysis on the complexes identified the most important enzyme-ligand interactions that account for the differences in activity within the series. A GRID/GOLPE analysis was then performed on just the ligands, in the conformations and orientations found in the modeled complexes. The results from both methods were concordant and confirmed the advantages of incorporating structural information from series of ligand-receptor complexes into 3D-QSAR methodologies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815771     DOI: 10.1023/a:1008164621650

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  36 in total

1.  Site-directed mutageneses of rat liver cytochrome P-450d: catalytic activities toward benzphetamine and 7-ethoxycoumarin.

Authors:  H Furuya; T Shimizu; K Hirano; M Hatano; Y Fujii-Kuriyama; R Raag; T L Poulos
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

2.  Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design.

Authors:  C Pérez; M Pastor; A R Ortiz; F Gago
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

3.  Chiral recognition at cytochrome P450 1A2 active site: effects of mutations at the putative distal site on the bindings of asymmetrical axial ligands.

Authors:  A G Krainev; T Shimizu; M Ishigooka; K Hiroya; M Hatano
Journal:  Biochemistry       Date:  1993-03-02       Impact factor: 3.162

4.  Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.

Authors:  G Cruciani; K A Watson
Journal:  J Med Chem       Date:  1994-08-05       Impact factor: 7.446

5.  The influence of structure on the accumulation of caffeine induced by methyl xanthine derivatives.

Authors:  J Segura; D J Roberts; E Tarrus
Journal:  J Pharm Pharmacol       Date:  1989-02       Impact factor: 3.765

6.  The cytochrome P450 1A2 active site: topology and perturbations caused by glutamic acid-318 and threonine-319 mutations.

Authors:  S F Tuck; K Hiroya; T Shimizu; M Hatano; P R Ortiz de Montellano
Journal:  Biochemistry       Date:  1993-03-16       Impact factor: 3.162

7.  Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam.

Authors:  T L Poulos; A J Howard
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

8.  Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes.

Authors:  T Shimada; F P Guengerich
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

9.  Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.

Authors:  U Fuhr; G Strobl; F Manaut; E M Anders; F Sörgel; E Lopez-de-Brinas; D T Chu; A G Pernet; G Mahr; F Sanz
Journal:  Mol Pharmacol       Date:  1993-02       Impact factor: 4.436

10.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

Authors:  T Shimada; M Iwasaki; M V Martin; F P Guengerich
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

View more
  17 in total

1.  CoMFA and docking study of novel estrogen receptor subtype selective ligands.

Authors:  Peter Wolohan; David E Reichert
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

2.  Development of biologically active compounds by combining 3D QSAR and structure-based design methods.

Authors:  Wolfgang Sippl
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

3.  How optimal are the binding energetics of barnase and barstar?

Authors:  Ting Wang; Sanja Tomic; Razif R Gabdoulline; Rebecca C Wade
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 4.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

5.  Interaction force diagrams: new insight into ligand-receptor binding.

Authors:  Hooman Shadnia; James S Wright; James M Anderson
Journal:  J Comput Aided Mol Des       Date:  2008-11-07       Impact factor: 3.686

6.  Identification of a less toxic vinca alkaloid derivative for use as a chemotherapeutic agent, based on in silico structural insights and metabolic interactions with CYP3A4 and CYP3A5.

Authors:  Nikhat Saba; Alpana Seal
Journal:  J Mol Model       Date:  2018-03-04       Impact factor: 1.810

Review 7.  5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy.

Authors:  Shufeng Zhou; Philip Kestell; Bruce C Baguley; James W Paxton
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

8.  Limiting assumptions in molecular modeling: electrostatics.

Authors:  Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2013-01-26       Impact factor: 3.686

9.  Comparative binding energy analysis of haloalkane dehalogenase substrates: modelling of enzyme-substrate complexes by molecular docking and quantum mechanical calculations.

Authors:  Jan Kmunícek; Michal Bohác; Santos Luengo; Federico Gago; Rebecca C Wade; Jirí Damborský
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

10.  Comprehensive model of wild-type and mutant HIV-1 reverse transciptases.

Authors:  Flavio Ballante; Ira Musmuca; Garland R Marshall; Rino Ragno
Journal:  J Comput Aided Mol Des       Date:  2012-07-26       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.